Terms: = Ovarian cancer AND NT5C2, ENSG00000076685, 22978, P49902, PNT5, NT5B, GMP, cN-II
35 results:
1. The STING pathway: Therapeutic vulnerabilities in ovarian cancer.
Shakfa N; Li D; Nersesian S; Wilson-Sanchez J; Koti M
Br J Cancer; 2022 Sep; 127(4):603-611. PubMed ID: 35383278
[TBL] [Abstract] [Full Text] [Related]
2. The SETDB1-TRIM28 Complex Suppresses Antitumor Immunity.
Lin J; Guo D; Liu H; Zhou W; Wang C; Müller I; Kossenkov AV; Drapkin R; Bitler BG; Helin K; Zhang R
Cancer Immunol Res; 2021 Dec; 9(12):1413-1424. PubMed ID: 34848497
[TBL] [Abstract] [Full Text] [Related]
3. Ex vivo expanded allogeneic natural killer cells have potent cytolytic activity against cancer cells through different receptor-ligand interactions.
Jung D; Baek YS; Lee IJ; Kim KY; Jang H; Hwang S; Jung J; Moon YW; Park KS; Choi YS; An HJ
J Exp Clin Cancer Res; 2021 Oct; 40(1):333. PubMed ID: 34686187
[TBL] [Abstract] [Full Text] [Related]
4. Synthesis and antiproliferative activity of hindered, chiral 1,2-diaminodiamantane platinum(II) complexes.
Bakhonsky VV; Pashenko AA; Becker J; Hausmann H; De Groot HJM; Overkleeft HS; Fokin AA; Schreiner PR
Dalton Trans; 2020 Oct; 49(40):14009-14016. PubMed ID: 33078783
[TBL] [Abstract] [Full Text] [Related]
5. ovarian cancer Cells Commonly Exhibit Defective STING Signaling Which Affects Sensitivity to Viral Oncolysis.
de Queiroz NMGP; Xia T; Konno H; Barber GN
Mol Cancer Res; 2019 Apr; 17(4):974-986. PubMed ID: 30587523
[TBL] [Abstract] [Full Text] [Related]
6. A protocol to isolate and qualify purified human preantral follicles in cases of acute leukemia, for future clinical applications.
Mouloungui E; Zver T; Roux C; Amiot C
J Ovarian Res; 2018 Jan; 11(1):4. PubMed ID: 29304838
[TBL] [Abstract] [Full Text] [Related]
7. Molecular, cellular and pharmacological effects of platinum(II) diiodido complexes containing 9-deazahypoxanthine derivatives: A group of broad-spectrum anticancer active agents.
Vančo J; Trávníček Z; Křikavová R; Gáliková J; Dvořák Z; Chalupová M
J Photochem Photobiol B; 2017 Aug; 173():423-433. PubMed ID: 28662469
[TBL] [Abstract] [Full Text] [Related]
8. Nanoscale Coordination Polymers Codeliver Carboplatin and Gemcitabine for Highly Effective Treatment of Platinum-Resistant ovarian cancer.
Poon C; Duan X; Chan C; Han W; Lin W
Mol Pharm; 2016 Nov; 13(11):3665-3675. PubMed ID: 27712076
[TBL] [Abstract] [Full Text] [Related]
9. Platinum(II) carboxylato complexes containing 7-azaindoles as N-donor carrier ligands showed cytotoxicity against cancer cell lines.
Štarha P; Trávníček Z; Pazderová L; Dvořák Z
J Inorg Biochem; 2016 Sep; 162():109-116. PubMed ID: 27350081
[TBL] [Abstract] [Full Text] [Related]
10. (18)F-nanobody for PET imaging of HER2 overexpressing tumors.
Xavier C; Blykers A; Vaneycken I; D'Huyvetter M; Heemskerk J; Lahoutte T; Devoogdt N; Caveliers V
Nucl Med Biol; 2016 Apr; 43(4):247-52. PubMed ID: 27067045
[TBL] [Abstract] [Full Text] [Related]
11. Photosensitive Pt(IV)-azide prodrug-loaded nanoparticles exhibit controlled drug release and enhanced efficacy in vivo.
Xiao H; Noble GT; Stefanick JF; Qi R; Kiziltepe T; Jing X; Bilgicer B
J Control Release; 2014 Jan; 173():11-7. PubMed ID: 24511610
[TBL] [Abstract] [Full Text] [Related]
12. Rebmab200, a humanized monoclonal antibody targeting the sodium phosphate transporter NaPi2b displays strong immune mediated cytotoxicity against cancer: a novel reagent for targeted antibody therapy of cancer.
Lopes dos Santos M; Yeda FP; Tsuruta LR; Horta BB; Pimenta AA; Degaki TL; Soares IC; Tuma MC; Okamoto OK; Alves VA; Old LJ; Ritter G; Moro AM
PLoS One; 2013; 8(7):e70332. PubMed ID: 23936189
[TBL] [Abstract] [Full Text] [Related]
13. Proteomic analyses of different human tumour-derived chaperone-rich cell lysate (CRCL) anti-cancer vaccines reveal antigen content and strong similarities amongst the vaccines along with a basis for CRCL's unique structure: CRCL vaccine proteome leads to unique structure.
Mayer-Sonnenfeld T; Har-Noy M; Lillehei KO; Graner MW
Int J Hyperthermia; 2013 Sep; 29(6):520-7. PubMed ID: 23734882
[TBL] [Abstract] [Full Text] [Related]
14. Cyclic gmp/protein kinase G type-Iα (PKG-Iα) signaling pathway promotes CREB phosphorylation and maintains higher c-IAP1, livin, survivin, and Mcl-1 expression and the inhibition of PKG-Iα kinase activity synergizes with cisplatin in non-small cell lung cancer cells.
Wong JC; Bathina M; Fiscus RR
J Cell Biochem; 2012 Nov; 113(11):3587-98. PubMed ID: 22740515
[TBL] [Abstract] [Full Text] [Related]
15. Evaluation of anionic half generation 3.5-6.5 poly(amidoamine) dendrimers as delivery vehicles for the active component of the anticancer drug cisplatin.
Kirkpatrick GJ; Plumb JA; Sutcliffe OB; Flint DJ; Wheate NJ
J Inorg Biochem; 2011 Sep; 105(9):1115-22. PubMed ID: 21704583
[TBL] [Abstract] [Full Text] [Related]
16. Protein kinase G type Ialpha activity in human ovarian cancer cells significantly contributes to enhanced Src activation and DNA synthesis/cell proliferation.
Leung EL; Wong JC; Johlfs MG; Tsang BK; Fiscus RR
Mol Cancer Res; 2010 Apr; 8(4):578-91. PubMed ID: 20371672
[TBL] [Abstract] [Full Text] [Related]
17. DNA cleavage and antitumour activity of platinum(II) and copper(II) compounds derived from 4-methyl-2-N-(2-pyridylmethyl)aminophenol: spectroscopic, electrochemical and biological investigation.
Roy S; Maheswari PU; Lutz M; Spek AL; den Dulk H; Barends S; van Wezel GP; Hartl F; Reedijk J
Dalton Trans; 2009 Dec; (48):10846-60. PubMed ID: 20023915
[TBL] [Abstract] [Full Text] [Related]
18. Role of soluble guanylyl cyclase-cyclic gmp signaling in tumor cell proliferation.
Mujoo K; Sharin VG; Martin E; Choi BK; Sloan C; Nikonoff LE; Kots AY; Murad F
Nitric Oxide; 2010 Jan; 22(1):43-50. PubMed ID: 19948239
[TBL] [Abstract] [Full Text] [Related]
19. Synthesis, characterization, and reaction pathways for the formation of a gmp adduct of a cytotoxic thiocyanato ruthenium arene complex.
Wang F; Habtemariam A; van der Geer EP; Deeth RJ; Gould R; Parsons S; Sadler PJ
J Biol Inorg Chem; 2009 Sep; 14(7):1065-76. PubMed ID: 19499253
[TBL] [Abstract] [Full Text] [Related]
20. gmp production of anti-tumor cytotoxic T-cell lines for adoptive T-cell therapy in patients with solid neoplasia.
Turin I; Pedrazzoli P; Tullio C; Montini E; La Grotteria MC; Schiavo R; Perotti C; Locatelli F; Carretto E; Maccario R; Siena S; Montagna D
Cytotherapy; 2007; 9(5):499-507. PubMed ID: 17786611
[TBL] [Abstract] [Full Text] [Related]
[Next]